Wealthspire Advisors (Maryland)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Wealthspire Advisors (Maryland)'s EW Position: Q3 2020 in Review
Wealthspire Advisors (Maryland) reduced its Edwards Lifesciences (EW) stake by 16% in Q3 2020, selling an estimated $91.7K and leaving 6,144 shares worth $490K. The position accounts for 0.02% of the portfolio, ranked #275.
Wealthspire Advisors (Maryland) first reported a position in EW in Q4 2015 and has held it in 20 quarters since. The position peaked at $546K in Q4 2019. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.
- Wealthspire Advisors (Maryland) held 6,144 shares of Edwards Lifesciences worth $490K as of Q3 2020.
- Wealthspire Advisors (Maryland) sold 1,175 Edwards Lifesciences shares in Q3 2020, an estimated $91.7K.
- Edwards Lifesciences made up 0.02% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #275 holding.
- Wealthspire Advisors (Maryland) first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 20 quarters since.
- Wealthspire Advisors (Maryland)'s Edwards Lifesciences position peaked at $546K in Q4 2019.
- 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.
Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.